Royalty Pharma plc (RPRX) › Shareholders' EquityRoyalty Pharma plc (RPRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $4.46B2018: $4.55B2019: $6.14B2020: $9.90B2021: $10.25B2022: $9.53B2023: $10.08B2024: $10.34B2025: $9.71B$9.71B2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$9.71B-6.1%2024$10.34B+2.6%2023$10.08B+5.9%2022$9.53B-7.1%2021$10.25B+3.6%2020$9.90B+61.1%2019$6.14B+34.9%2018$4.55B+2.1%2017$4.46B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share